384
Views
9
CrossRef citations to date
0
Altmetric
Clinical Research

Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation

, , ORCID Icon &
Pages 211-218 | Received 10 Feb 2020, Accepted 26 Feb 2020, Published online: 18 Mar 2020

References

  • Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant mesothelioma and its non-Asbestos causes. Arch Pathol Lab Med. 2018;142:753. doi:10.5858/arpa.2017-0365-RA.
  • Roggli VL, Sharma A. Analysis of tissue mineral fiber content, Ch. 11. In: Oury TD, Sporn TA, Roggli VL, eds. Pathology of Asbestos Associated Diseases. 3rd ed. New York: Springer; 2014:253.
  • Pavlisko EN. Sporn TA: Mesothelioma, Ch. 5. In: Oury TD, Sporn TA, Roggli VL, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York: Springer; 2014:81.
  • Oczypok EA, Sanchez MS, Van Orden DR, et al. Erionite-associated malignant pleural mesothelioma in North America. Int J Clin Exp Pathol. 2016;9:5722.
  • Artvinli M, Baris YI. Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study. J Natl Cancer Inst. 1979;63:17.
  • Paoletti L, Batisti D, Bruno C, et al. Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Heath. 2000;55:392. doi:10.1080/00039890009604036.
  • Roggli VL, Vollmer RT, Butnor KJ, Sporn TA. Tremolite and mesothelioma. Ann Occup Hyg. 2002;46:447.
  • Whitehouse AC, Black CB, Heppe MS, Ruckdeschel J, Levin SM. Environmental exposure to Libby asbestos and mesotheliomas. Am J Ind Med. 2008;51:877.
  • Miller A, Teirstein AS, Bader MD, Bader RA, Selikoff IJ. Talc pneumoconiosis: significance of sublight microscopic mineral particles. Am J Med. 1971;50:395.
  • Finley BL, Benson SM, Marsh GM. Cosmetic talc as a risk factor for pleural mesothelioma: A weight of evidence evaluation of the epidemiology. Inhal Toxicol. 2017;29:179. doi:10.1080/08958378.2017.1336187.
  • Finkelstein M, Letter R, Glynn ME, Keeton KA, Gaffney SH, Sahmel J. Ambient Asbestos fiber concentrations and long-term trends in pleural mesothelioma incidence between urban and rural areas in the United States (1973-2012). Risk Anal. 2018;38:1521. doi:10.1111/risa.13124.
  • Langer AM, Nolan RP, Pooley FD. Phyllosilicates: associated fibrous minerals, In: health-Related Effects of Phyllosilicates (Bignon J, ed.). NATO Series. 1991;G21:59.
  • Roggli VL, Shelburne JD. New concepts in the diagnosis of mineral pneumoconioses. In: lung Pathology for the Clinician (Greenberg SD, ed.). Sem Respir Med. 1982;4:138. doi:10.1055/s-2007-1012478.
  • Roggli VL, Ingram P, Linton RW, Gutknecht WF, Mastin P, Shelburne JD. New techniques for imaging and analyzing lung tissue. Environ Health Persp. 1984;56:163. doi:10.1289/ehp.8456163.
  • Roggli VL, Greenberg SD. Analytical electron microscopy and pulmonary toxicology: an overview. In: Romig AD Jr, Chambers WF, eds. Microbeam Analysis-1986. San Francisco: San Francisco Press, Inc.; 1986:539.
  • Roggli VL. Nonasbestos mineral fibers from human lungs. In: Russell PE, ed. Microbeam Analysis - 1989. San Francisco: San Francisco Press, Inc.; 1989:57.
  • Husain AN, Colby TV, Ordonez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018;142:89. doi:10.5858/arpa.2017-0124-RA.
  • Churg A, Cagle PT, Roggli VL. Tumors of the Serosal Membranes, AFIP Atlas of Tumor Pathology, Series IV, Fascicle 3. Washington, DC: American Registry of Pathology; 2006.
  • Sporn TA, Roggli VL. Asbestosis, Ch. 4. In: Oury TD, Sporn TA, Roggli VL, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. New York: Springer; 2014:53.
  • Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis: an update of the diagnostic criteria. Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010;134:462.
  • Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: A light and scanning electron microscopic analysis of 18 cases. Mod Pathol. 1995;8:614.
  • Roggli VL. Asbestos bodies and non-asbestos ferruginous bodies, Ch. 3. In: Oury TD, Sporn TA, Roggli VL, eds. Pathology of Asbestos-Associated Diseases. 3rd ed. Springer: New York; 2014:25.
  • Roggli VL, McGavran MH, Subach JA, Sybers HD, Greenberg SD. Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: A study of 25 cases. Cancer. 1982;50:2423. doi:10.1002/1097-0142(19821201)50:11<2423::AID-CNCR2820501130>3.0.CO;2-I.
  • Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: A clinical pathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26:55.
  • Roggli VL, Vollmer RT. 25 years of fiber analysis: what have we learned? Hum Pathol. 2008;39:307. doi:10.1016/j.humpath.2007.07.005.
  • Srebro SH, Roggli VL. Asbestos-related disease associated with exposure to asbestiform tremolite. Am J Ind Med. 1994;26:809. doi:10.1002/()1097-0274.
  • Butnor KJ, Sporn TA, Roggli VL. Exposure to brake dust and malignant mesothelioma: A study of 10 cases with mineral fiber analyses. Ann Occup Hyg. 2003;47:325.
  • Marsh GM, Youk AO, Roggli VL. Asbestos fiber concentrations in the lungs of brake repair workers: commercial amphibole levels are predictive of chrysotile levels. Inhal Toxicol. 2011;12:681. doi:10.3109/08958378.2011.580472.
  • Liu Y, Marsh GM, Roggli VL. Asbestos fiber concentrations in the lungs of brake repair workers: an updated analysis using several regression methods to handle non-detectable measurements. J Occup Environ Med. 2018;60:661. doi:10.1097/JOM.0000000000001320.
  • Churg A. Nonasbestos pulmonary mineral fibers in the general population. Environ Res. 1983;31:189. doi:10.1016/0013-9351(83)90075-0.
  • Roggli VL. Measuring EMPs in the lung: what can be measured in the lung: asbestiform minerals and cleavage fragments. Toxicol Appl Pharmacol. 2018;361:14. doi:10.1016/j.taap.2018.06.026.
  • Henderson DW, Rantanen J, Barnhart S, et al. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. A consensus report of an international expert group. Scand J Work Environ Health. 1997;23:311.
  • Roggli VL, Green CL. Dimensions of elongated mineral particles: A study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asbestiform vs. cleavage fragments. Ultrastruct Pathol. 2019;43:1. doi:10.1080/01913123.2019.1566298.
  • Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;14:565. doi:10.1016/S0003-4878(00)00045-4.
  • Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(S1):1. doi:10.1080/10408440802276167.
  • Garabrant DH, Pastula ST. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol. 2018;361:127. doi:10.1016/j.taap.2018.07.003.
  • Korchevskiy A, Rasmuson JO, Rasmuson EJ. Empirical model of mesothelioma potency factors for different mineral fibers based on their chemical composition and dimensionality. Inhal Toxicol. 2019;31:180. doi:10.1080/08958378.2019.1640320.
  • Wagner J, Berry G, Cooke T, Hill R, Pooley F, Skidmore J: Animal experiments with talc. Inhaled Particles IV: Proceedings of an International Symposium, Part 2, Edinburgh, UK, 1977:647.
  • Wagner J, Berry G, Hill R, Skidmore J, Pooley F. An animal model for inhalation exposure to talc. In: Lemen R, Dement J, eds. Dusts and Disease. Park Forest South, IL: Pathotox Publishers; 1979:389.
  • Rubino G, Scansetti G, Piolatto G, Romano CA. Mortality study of talc miners and millers. J Occup Med. 1976;18:186. doi:10.1097/00043764-197603000-00013.
  • Rubino G, Scansetti G, Piolatto G, Gay G. Mortality and morbidity among talc miners and millers in Italy. In: Lemen R, Dement J, eds. Dusts and Disease. Park Forest South, IL: Pathotox Publishers; 1979:357.
  • Coggiola M, Bosio D, Pira E, et al. An update of a mortality study of talc miners and millers in Italy. Am J Ind Med. 2003;44:63. doi:10.1002/()1097-0274.
  • Pira E, Coggiola M, Ciocan C, et al. Mortality of talc miners and millers from Val Chisone, Northern Italy: an updated cohort study. J Occup Environ Med. 2017;59:659. doi:10.1097/JOM.0000000000000992.
  • Wergeland E, Andersen A, Baerheim A. Morbidity and mortality in talc-exposed workers. Am J Ind Med. 1990;17:505. doi:10.1002/ajim.4700170408.
  • Wergeland E, Gjersten F, Vos L, Grimsrud T. Cause-specific mortality and cancer morbidity in 390 male workers exposed to high purity talc, a six-decade follow-up. Am J Ind Med. 2017;60:821. doi:10.1002/ajim.22749.
  • Wild P, Leodolter K, Refregier M, Schmidt H, Zidek T, Haidinger G. A cohort mortality and nested case-control study of French and Austrian talc workers. Occup Environ Med. 2002;59:98. doi:10.1136/oem.59.2.98.
  • Selevan S, Dement J, Wagoner J, Froines J. Mortality patterns among miners and millers of non-asbestiform talc: preliminary report. In: Lemen R, Dement J, eds. Dusts and Disease. Park Forest South, IL: Pathotox Publishers; 1979:379.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.